SAN FRANCISCO--(BUSINESS WIRE)--Archimedes Inc., a healthcare modeling company, today announced a collaboration with Novo Nordisk A/S, a world leader in diabetes care, to evaluate the effects of standardized vascular health checks on expected health outcomes. Archimedes will simulate these effects in a variety of European populations using the Archimedes Model.
Archimedes will generate a simulated population of patients that matches the demographic characteristics and other risk factors in the United Kingdom, Germany, France, Poland, Italy and Denmark. The health check, a multi-faceted preventative intervention, will be simulated in a variety of ways, but will be modeled after the program outlined in the Best Practice Guidance designed by the United Kingdom National Health Service.
Peter Alperin, M.D., Archimedes’ vice president of medicine said, "Our collaboration with Novo Nordisk complements the work we have been doing within the healthcare industry to demonstrate the benefits of healthcare modeling when determining the best approaches to clinical care. The partnership adds further confirmation that the industry is interested in evaluating the potential benefits of various interventions using healthcare modeling, which can provide an accurate representation of how patient outcomes are affected by different interventions."
The simulation, which will forecast the effects of such checks over a period of 30 years, has already commenced. Researchers hope that quantitative information on the benefits of the health check will encourage increased participation. The study is expected to conclude during the first half of 2012, at which time the companies will determine the best means of disseminating the results.
ABOUT ARCHIMEDES
Archimedes, Inc. is an independent healthcare modeling organization. Its core technology - the Archimedes Model - is a carefully validated and calibrated simulation model of health and healthcare.
The Model allows people to simulate clinical trials, perform complex health economics and outcomes research, assist with portfolio strategy, and analyze health policies and guidelines. The Archimedes Model helps people understand the implications of the decisions they are faced with and for the last 15 years has been relied upon to answer complex, real-world questions for managed care organizations, pharmaceutical companies, and other healthcare organizations. Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California. For more information on the company, visit our website at www.archimedesmodel.com.